- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Oncologists Raise a Voice Against Cancer Drug Costs
Hagop Kantarjian, MD, from MD Anderson is at it again. A special publication online, written in collaboration with S. Vincent Kumar, MD, from the Mayo Clinic, highlights the dismal state of the economics behind high oncology drug costs and recommends solutions.
Increasingly high prices for cancer drugs are affecting patient care in the United States. and the American healthcare system overall, say the authors of a special article published online in the journal Mayo Clinic Proceedings.
“Americans with cancer pay 50 percent to 100 percent more for the same patented drug than patients in other countries,” says S
, of Mayo Clinic Cancer Center
,
who is one of the authors. “As oncologists we have a moral obligation to advocate for affordable cancer drugs for our patients.”
. Vincent Raj Kumar
Link to the news release by the Mayo Clinic: http://mayocl.in/1Gd7cMB
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
